Implementation of PPACA.
Patent Reform Act of 2009.
Duration: November 1, 2007
to
June 30, 2010
General Issues: Health Issues , Medicare/Medicaid , Copyright/Patent/Trademark , Taxation/Internal Revenue Code
Spending: about $630,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: House of Representatives, U.S. Senate,, U.S. Senate, Health & Human Services - Dept of (HHS), White House Office, Commerce - Dept of (DOC), Y
Y
House of Representatives; Senate; Department of Health and Human Services; White House
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Cecil Swamidoss Legal Intern, US Sen. Spec. Cmte on Aging (1998)
Depty Investigator, US Sen. Spec. Cmte on Aging
(1999-2001); Investigative Counsel, US Sen. Cmte
on Finance (2001); Investigative Counsel, US
Sen. Spec. Cmte on Aging (2001-2003); Senior
Counsel, US Sen. Spec. Cmte on Aging (2004-
2008).
Judith Lemons Chief of Staff, Congresswomen Nancy Pelosi.
Gary Andres n/a
Darren Willcox n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2010
DUTKO WORLDWIDE, LLC terminated an engagement in which they represented GENENTECH, INC on July 14, 2010.
Original Filing: 300286598.xml
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Patent Reform Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2010
In Q1, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $60,000. The report was filed on April 7, 2010.
Original Filing: 300255037.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679),America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Physician Payments Sunshine Act of 2009 (S. 301).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid/Patent/Trademark
4th Quarter, 2009
In Q4, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $80,000. The report was filed on Dec. 31, 2009.
Original Filing: 300227028.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679),America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Physician Payments Sunshine Act of 2009 (S. 301).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid/Patent/Trademark
3rd Quarter, 2009
In Q3, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $70,000. The report was filed on Oct. 1, 2009.
Original Filing: 300199867.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned).Pharmaceutical import safety legislation. Physician Payments Sunshine Act of 2009 (S. 301).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned).Pharmaceutical import safety legislation. Physician Payments Sunshine Act of 2009 (S. 301).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2009
In Q2, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $60,000. The report was filed on July 14, 2009.
Original Filing: 300176339.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation. Physician Payments Sunshine Act of 2009 (S. 301).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation. Physician Payments Sunshine Act of 2009 (S. 301).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2009
DUTKO WORLDWIDE, LLC amended a lobbying report for representation of GENENTECH, INC in Q12009 on April 13, 2009.
Original Filing: 300147101.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2009
In Q1, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $60,000. The report was filed on April 9, 2009.
Original Filing: 300145409.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548). Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2008
In Q4, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $60,000. The report was filed on Jan. 7, 2009.
Original Filing: 300114137.xml
Lobbying Issues
Monitor legislation pertaining to Medicare, healthcare and related issues, including Patent Reform Act of 2007 (HR 1908/S 1145),
Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor legislation pertaining to health care intellectual property, including Patent Reform Act of 2007 (HR 1908/S 1145),
Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2008
In Q3, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $60,000. The report was filed on Oct. 7, 2008.
Original Filing: 300088626.xml
Lobbying Issues
Monitor legislation pertaining to Medicare, healthcare and related issues, including Patent Reform Act of 2007 (HR 1908/S 1145),
Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor legislation pertaining to patent issues, including Patent Reform Act of 2007 (HR 1908/S 1145),
Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR 5629).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2008
In Q2, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $60,000. The report was filed on July 8, 2008.
Original Filing: 300061585.xml
Lobbying Issues
Monitor legislation pertaining to Medicare, healthcare and related issues, including Patent Reform Act of 2007 (HR1908/S1145),
Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR5629).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor legislation pertaining to patents, healthcare and related issues, including Patent Reform Act of 2007 (HR1908/S1145),
Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Pathway for Biosimilars Act (HR5629).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2008
In Q1, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $60,000. The report was filed on April 3, 2008.
Original Filing: 300032268.xml
Lobbying Issues
Monitor legislation pertaining to Medicare, healthcare and related issues, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, Pathway for Biosimilars Act (HR5629).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affect them, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, Pathway for Biosimilars Act (HR5629).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
0th Quarter, 2007
In MM, DUTKO WORLDWIDE, LLC lobbied for GENENTECH, INC , earning $90,000. The report was filed on Aug. 3, 2007.
Original Filing: 200045686.xml
Lobbying Issues
Monitor legislation pertaining to Medicare, healthcare and related tax issues
Agencies Lobbied
Y
Y
House of Representatives; Senate; Department of Health and Human Services; White House
Type of Issue
Health Issues/Medicaid/Internal Revenue Code
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...